Drugs / Shenqu Xiaoshi Oral liquid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05515887 | Nov 2022 → Dec 2024 | dyspepsia | Ruijin Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shenqu Xiaoshi Oral liquid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05515887 ↗ |
| Route | Oral | “Shenqu Xiaoshi Oral liquid will be taken orally.” NCT05515887 ↗ |